Literature DB >> 30857828

An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets.

Xu Wu1, Jing Shen1, Zhangang Xiao1, Jing Li2, Yueshui Zhao1, Qijie Zhao1, Chi Hin Cho3, Mingxing Li4.   

Abstract

MicroRNAs (miRNAs) are a group of small non-coding RNAs that have displayed strong association with gastric cancer (GC). Through the repression of target mRNAs, miRNAs regulate many biological pathways that are involved in cell proliferation, apoptosis, migration, invasion, metastasis as well as drug resistance. The detection of miRNAs in tissues and in body fluids emerges as a promising method in the diagnosis and prognosis of GC, due to their unique expression pattern in correlation with GC. Notably, miRNAs are also identified as potential therapeutic targets for GC therapy. The present review is thus to highlight the multifaceted roles of miRNAs in GC and in GC therapies, which would give indications for future research.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug resistance; Gastric cancer; Therapeutic targets; miRNA

Mesh:

Substances:

Year:  2019        PMID: 30857828     DOI: 10.1016/j.bcp.2019.03.011

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

Review 1.  Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis.

Authors:  Irina V Bure; Marina V Nemtsova; Ekaterina B Kuznetsova
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

2.  Long noncoding RNA SNHG16 silencing inhibits the aggressiveness of gastric cancer via upregulation of microRNA-628-3p and consequent decrease of NRP1.

Authors:  Weifeng Pang; Mingcui Zhai; Yue Wang; Zhiqiang Li
Journal:  Cancer Manag Res       Date:  2019-08-01       Impact factor: 3.989

Review 3.  Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected.

Authors:  Irina V Bure; Marina V Nemtsova
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

4.  The Aberrant Expression of MicroRNA-125a-5p/IGF2BP3 Axis in Advanced Gastric Cancer and Its Clinical Relevance.

Authors:  Jing Zhang; Fanghui Ding; Dan Jiao; Qiaozhi Li; Hong Ma
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.